Insider at Conexeu Sciences (CNXU) adds common stock and warrants

Filing Impact

(Moderate)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Conexeu Sciences Inc. director and 10% owner Lynn Sebastian Purcell, through OnePointTwo Capital Ventures LLC, reported significant indirect insider activity in common stock and warrants on 2026-06-18. The LLC bought 202,500 shares of common stock at $0.80 per share, bringing its indirect common stock holdings to 2,734,240 shares. It also exercised warrants for 202,500 underlying common shares at an exercise price of $0.80 and separately bought 202,500 additional warrants at $0.001 per warrant, each exercisable for common stock at $2.30 per share, leaving 625,000 warrants indirectly held.

Insights

Indirect owner increases CNXU exposure via stock and warrant buys.

OnePointTwo Capital Ventures LLC, associated with director and 10% owner Lynn Sebastian Purcell, made a net insider net-buy in Conexeu Sciences on 2026-06-18. It purchased 202,500 common shares at $0.80 and added 202,500 warrants while exercising another 202,500-share warrant position.

This combines an open-market equity purchase with a derivative exercise, raising direct economic exposure to both current shares and future upside via warrants. Following the transactions, the LLC reports 2,734,240 common shares and 625,000 warrants held indirectly, indicating continued alignment with equity performance.

Insider Trade Summary

Net Buyer: 405,000 shares ($162,203)

Net Buy 3 txns

Insider Purcell Lynn Sebastian

Role null

Bought 405,000 shs ($162K)

Type	Security	Shares	Price	Value
Purchase	Warrant	202,500	$0.001	$202.50
Exercise	Warrant	202,500	$0.80	$162K
Purchase	Common Stock	202,500	$0.80	$162K

Holdings After Transaction: Warrant — 625,000 shares (Indirect, By OnePointTwo Capital Ventures LLC); Common Stock — 2,734,240 shares (Indirect, By OnePointTwo Capital Ventures LLC)

Footnotes (1)

Key Figures

Common shares purchased: 202,500 shares at $0.80 Common shares held after: 2,734,240 shares Warrants exercised: 202,500 warrants at $0.80 +4 more

7 metrics

Common shares purchased 202,500 shares at $0.80 Open-market purchase on June 18, 2026

Common shares held after 2,734,240 shares Indirect common stock holdings after transactions

Warrants exercised 202,500 warrants at $0.80 Exercise of warrants into common stock on June 18, 2026

New warrants purchased 202,500 warrants at $0.001 Derivative purchase on June 18, 2026, strike $2.30

Warrants held after 625,000 warrants Indirect warrant holdings following all June 18, 2026 trades

New warrant exercise price $2.30 per share Exercise price of warrants bought at $0.001

New warrant expiration April 30, 2029 Expiration date of warrants bought on June 18, 2026

Key Terms

open-market purchase, derivative exercise/conversion, Warrant, indirect

4 terms

open-market purchase financial

"transaction_action: "open-market purchase" for common stock and warrants"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion" for the warrant exercise"

Warrant financial

"security_title: "Warrant" with underlying security title "Common Stock""

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

indirect financial

"ownership_type: "indirect" and nature_of_ownership: "By OnePointTwo Capital Ventures LLC""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/23/2026 - 08:16 PM Accepted by SEC EDGAR 06/23/2026 - 08:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Purcell Lynn Sebastian

(Last)

(First)

(Middle)

69 STATE STREET

SUITE 1300 PMB 2034

(Street)

ALBANY

NEW YORK

12207

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Conexeu Sciences Inc. [ CNXU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/18/2026		P		202,500	A	$0.8	2,734,240	I	By OnePointTwo Capital Ventures LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrant	$2.3	06/18/2026		P		202,500		05/12/2026	04/30/2029	Common Stock	202,500	$0.001	625,000	I	By OnePointTwo Capital Ventures LLC
Warrant	$0.8	06/18/2026		M			202,500	06/04/2025	01/15/2027	Common Stock	202,500	$0.8	625,000	I	By OnePointTwo Capital Ventures LLC

Explanation of Responses:

	Lynn Sebastian Purcell	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions were reported for CNXU on June 18, 2026?

On June 18, 2026, an entity linked to CNXU director and 10% owner Lynn Sebastian Purcell bought 202,500 common shares at $0.80 and 202,500 warrants, and exercised warrants for 202,500 underlying common shares.

Who executed the recent Conexeu Sciences (CNXU) insider trades?

The trades were made indirectly by OnePointTwo Capital Ventures LLC, an entity associated with director and 10% owner Lynn Sebastian Purcell. The filing attributes ownership and transactions to this LLC rather than to Purcell personally.

How many Conexeu Sciences shares does the insider entity hold after these trades?

After the June 18, 2026 transactions, OnePointTwo Capital Ventures LLC reports indirect ownership of 2,734,240 shares of Conexeu Sciences common stock. This reflects the updated position following the 202,500-share open-market purchase and related warrant exercise.

What warrant activity did the CNXU insider report on June 18, 2026?

The insider entity exercised warrants for 202,500 underlying Conexeu Sciences common shares at a $0.80 exercise price and separately bought 202,500 additional warrants at $0.001 each, with a $2.30 per-share exercise price and an expiration on April 30, 2029.

Is the recent Conexeu Sciences (CNXU) Form 4 mainly a buy or a sale?

The Form 4 reflects net-buy activity. It shows two open-market purchases totaling 405,000 securities (common shares and warrants) and one derivative exercise, with no reported sales or dispositions in this particular filing.